Go Pro
→ Why major institutions are piling into this digital asset now (From Awesomely) (Ad)tc pixel Free PBMWW Stock Alerts

Psyence Biomedical (PBMWW) Competitors

$0.03 0.00 (0.00%)
As of 08/21/2026 03:22 PM Eastern
Compare

PBMWW vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy Psyence Biomedical stock or one of its competitors? Psyence Biomedical's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Psyence Biomedical compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Psyence Biomedical (NASDAQ:PBMWW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Psyence Biomedical N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals' average media sentiment score of 1.99 beat Psyence Biomedical's score of 0.00 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Psyence Biomedical Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.11MN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Psyence Biomedical on 2 of the 2 factors compared between the two stocks.

How does Psyence Biomedical compare to Biofrontera?

Psyence Biomedical (NASDAQ:PBMWW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled Biofrontera'saverage media sentiment score.

Company Overall Sentiment
Psyence Biomedical Neutral
Biofrontera Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Biofrontera$46.18MN/AN/AN/AN/A

Summary

Biofrontera beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

How does Psyence Biomedical compare to Calithera Biosciences?

Psyence Biomedical (NASDAQ:PBMWW) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, earnings and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

In the previous week, Calithera Biosciences had 1 more articles in the media than Psyence Biomedical. MarketBeat recorded 1 mentions for Calithera Biosciences and 0 mentions for Psyence Biomedical. Psyence Biomedical's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company Overall Sentiment
Psyence Biomedical Neutral
Calithera Biosciences Neutral

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Calithera Biosciences N/A N/A N/A

Summary

Calithera Biosciences beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

How does Psyence Biomedical compare to Cingulate?

Psyence Biomedical (NASDAQ:PBMWW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

In the previous week, Psyence Biomedical's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Psyence Biomedical Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
Psyence BiomedicalN/A N/A N/A
Cingulate N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Psyence BiomedicalN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Summary

Psyence Biomedical and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.

How does Psyence Biomedical compare to Comera Life Sciences?

Comera Life Sciences (NASDAQ:CMRAW) and Psyence Biomedical (NASDAQ:PBMWW) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Comera Life SciencesN/A N/A N/A
Psyence Biomedical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Comera Life Sciences$1.00MN/AN/AN/AN/A
Psyence BiomedicalN/AN/AN/AN/AN/A

In the previous week, Comera Life Sciences' average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score.

Company Overall Sentiment
Comera Life Sciences Neutral
Psyence Biomedical Neutral

Summary

Comera Life Sciences beats Psyence Biomedical on 1 of the 1 factors compared between the two stocks.

Get Psyence Biomedical News Delivered to You Automatically

Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PBMWW vs. The Competition

Export
MetricPsyence BiomedicalPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$12.45B$7.27B$12.76B
Dividend YieldN/A2.64%2.54%11.08%
P/E RatioN/A784.87270.6924.20
Price / SalesN/A761.74639.89109.35
Price / CashN/A92.1276.8953.23
Price / BookN/A11.8513.436.37
Net IncomeN/A$2.80B$3.46B$347.74M
7 Day PerformanceN/A1.92%2.15%0.06%
1 Month PerformanceN/A3.70%6.18%2.86%
1 Year PerformanceN/A6.59%24.96%17.13%

Psyence Biomedical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PBMWW
Psyence Biomedical
N/A$0.03
flat		N/A+0.7%$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+7.3%		N/A-67.6%$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.03
+17.7%		N/A-69.9%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
+32.9%		N/A-81.8%$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:PBMWW) was last updated on 8/22/2026 by MarketBeat.com Staff.
From Our Partners
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...
Chaikin Analytics | Sponsoredtc pixel
Your Free Report (Inside)
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
23,281 stocks. Only ONE survived.
One American energy producer just cleared a screen of 23281 stocks for elite operating profits, double-digit r...
Monument Traders Alliance | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Someone just dumped the biggest gold fund.
Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...
Behind the Markets | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel